EVMN Form 144: Broker files sale of 9,258 shares

Morgan Stanley Smith Barney LLC filed a Form 144 reporting a proposed sale of 9,258 shares of Common StockEVMN on 06/02/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC filed a Form 144 reporting a proposed sale of 9,258 shares of Common StockEVMN on 06/02/2026. The filing lists an aggregate value of $205,249.86 and a reference figure 36,018,372 beside the filing row.

The filing breaks the 9,258 shares into prior allocations, includingPre-IPO purchase of 6,056 shares (06/23/2020) and Restricted Stock Awards of 3,202 shares (05/29/2020). No sales in the past three months are shown in the excerpt.

Insights

Equity Capital Markets Analyst

Broker notice lists a proposed sale of 9,258 EVMN common shares with a stated aggregate value.

The filing shows a broker-dealer notice under Form 144 for 9,258 shares with an aggregate dollar amount of $205,249.86. The excerpt lists two source categories for those shares dated 06/23/2020 and 05/29/2020.

Cash-flow treatment and whether the issuer or selling holder receives proceeds are not stated in the provided excerpt. Subsequent filings or the broker's sale confirmation would show timing and execution details.

Key Figures

Shares listed for sale: 9,258 shares Aggregate value: $205,249.86 Reference figure in row: 36,018,372 +2 more

5 metrics

Shares listed for sale 9,258 shares Form 144 row, filing dated <date>06/02/2026</date>

Aggregate value $205,249.86 Dollar amount shown in the same filing row

Reference figure in row 36,018,372 Numeric field appearing in the filing row (06/02/2026)

Pre-IPO purchase 6,056 shares Listed as 'Pre-IPO Purchase of Common Shares' dated <date>06/23/2020</date>

Restricted Stock Awards 3,202 shares Listed as 'Restricted Stock Awards' dated <date>05/29/2020</date>

Key Terms

Form 144, Pre-IPO Purchase, Restricted Stock Awards

3 terms

Form 144 regulatory

"filed a Form 144 reporting a proposed sale of 9,258 shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Pre-IPO Purchase financial

"Pre-IPO Purchase of Common Shares dated 06/23/2020"

Restricted Stock Awards financial

"Restricted Stock Awards dated 05/29/2020"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the EVMN Form 144 filed by Morgan Stanley mean?

It notifies the SEC of a proposed sale of 9,258 shares of EVMN common stock. The filing lists an aggregate value of $205,249.86 and source rows that account for those shares with their original grant/purchase dates.

How many EVMN shares are listed for sale in the excerpt?

The excerpt lists 9,258 shares proposed for sale. It also shows component entries of 6,056 shares from a Pre-IPO purchase and 3,202 shares from Restricted Stock Awards.

Does the Form 144 show sales already executed in the past three months for EVMN?

The excerpt indicates the section 'Securities Sold During The Past 3 Months' but contains no entries. The provided content shows no recorded sales in that section within the excerpt.

What date is associated with the Form 144 excerpt for EVMN?

The filing row in the excerpt includes the date 06/02/2026. Other relevant dates tied to the securities are 06/23/2020 and 05/29/2020 for the original allocations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:37 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001347383
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Evommune, Inc.
SEC File Number	001-42938
Address of Issuer	1891 Page Mill Road Palo Alto CALIFORNIA 94304
Phone	925-247-4481
Name of Person for Whose Account the Securities are To Be Sold	DAVID COHEN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9258	205249.86	36018372	06/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/23/2020	Pre-IPO Purchase of Common Shares	Issuer			6056	06/23/2020	N/A
Common	05/29/2020	Restricted Stock Awards	Issuer			3202	05/29/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of Pre-IPO Purchase of Common Shares during the period of 06/23/2020 through 12/28/2020.
Date of Notice	06/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Cohen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)